Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Topical finasteride may help treat facial hirsutism in women.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

New method accurately measures finasteride in tablets and bulk.

The compounds tested could potentially treat hair loss and alopecia.

Androsterone and finasteride have different solid forms, with new findings correcting previous errors and identifying a new form.

New vitamin D3 forms need the vitamin D receptor to reduce fibrosis in human cells.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

Frontal fibrosing alopecia in postmenopausal women can be managed with early treatment using corticosteroids to stop hair loss.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Nail loss may be a side effect of the MS drug teriflunomide.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Health warnings and public health actions led to a significant drop in flutamide prescriptions for women, but off-label use still continues.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Combining laser and corticosteroid is not better than corticosteroid alone for treating frontal fibrosing alopecia.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

A new method efficiently modifies alkenes to create useful medicinal compounds.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.